Grading of late effects in young adult survivors of childhood cancer followed in an ambulatory adult setting

Cancer

Volumn 88, Issue 7, 2000, Pages 1687-1695

  Oeffinger, Kevin C ^a   Eshelman, Debra A ^a   Tomlinson, Gail E ^b   Buchanan, George R ^b   Foster, Barbara M ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b CHILDREN S MEDICAL CENTER   (United States)

Author keywords

Adolescence; Child; Common Toxicity Criteria; Follow up studies; Late effects; Neoplasm; Survivors; Transition; Young adult

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTHRACYCLINE ANTIBIOTIC AGENT; ANTIMETABOLITE; ANTINEOPLASTIC AGENT; BLEOMYCIN; CARMUSTINE; CHLORMETHINE; CISPLATIN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DACTINOMYCIN; ETOPOSIDE; LOMUSTINE; PROCARBAZINE; VINCRISTINE;

ADOLESCENT; ADULT; AMBULATORY CARE; ARTICLE; CANCER GRADING; CANCER SURVIVAL; CANCER THERAPY; CHILDHOOD CANCER; DENTAL CARE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FEMALE; HODGKIN DISEASE; HUMAN; LABORATORY TEST; LEUKEMIA; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MAMMOGRAPHY; NEPHROBLASTOMA; NONHODGKIN LYMPHOMA; PATIENT MONITORING; PRIORITY JOURNAL; RADIODENSITOMETRY; SARCOMA; SCREENING TEST; THORAX RADIOGRAPHY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS; CHILD; CONTINUITY OF PATIENT CARE; FEMALE; FOLLOW-UP STUDIES; HEALTH STATUS; HUMANS; MALE; NEOPLASMS; RADIOTHERAPY; SURVIVORS;

EID: 0034177225     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(20000401)88:7<1687::AID-CNCR24>3.0.CO;2-M     Document Type: Article

References (25)

1. Robison LL. Issues in the consideration of intervention strategies in long-term survivors of childhood cancer. Cancer 1993;71:3406-10.
2. Meadows AT, Gallagher JA, Bunin GR, Late effects of early childhood cancer therapy. Br J Cancer 1992;66:S92-5.
3. Green DM. Long term complications of treatment for cancer during childhood and adolescence. Baltimore: Johns Hopkins University Press, 1989:1-165.
4. DeLaat CA, Lampkin BC. Long-term survivors of childhood cancer: evaluation and identification of sequelae of treatment. CA Cancer J Clin 1992;42:263-82.
5. Meister LA, Meadows AT. Late effects of childhood cancer therapy. Curr Probl Pediatr 1993;23:102-24.
6. Oeffinger KC, Eshelman DA, Tomlinson GE, Buchanan GR. Programs for adult survivors of childhood cancer. J Clin Oncol 1998;16:2864-7.
7. Bleyer WA, Smith RA, Green DM, DeLaat CA, Lampkin BC, Coltman CA, et al. Workgroup #1: Long-term care and lifetime follow-up. Cancer 1993;71:2410-25.
8. Rosen DS. Transition to adult health care for adolescents and young adults with cancer. Cancer 1993;71:3411-4.
9. Konsler GK, Jones GR. Transition issues for survivors of childhood cancer and their healthcare providers. Cancer Pract 1993;1:319-24.
10. Maclean WE, Foley GV, Ruccione K, Sklar C. Transitions in the care of adolescent and young adult survivors of childhood cancer. Cancer 1996;78:1340-4.
11. Meadows AT, Black B, Nesbit ME, Strong LC, Nicholson HS, Green DM, et al. Long-term survival: clinical care, research, and education. Cancer 1993;71:3213-5.
12. Garré ML, Gandus S, Cesana B, Haupt R, De Bernardi B, Comelli A, et al. Health status of long-term survivors after cancer in childhood. Am J Pediatr Hematol Oncol 1994;16: 143-52.
13. von der Weid N, Beck D, Caflisch U, Feldges A, Wyss M, Wagner HP. Standardized assessment of late effects in long-term survivors of childhood cancer in Switzerland: results of a Swiss Pediatric Oncology Group (SPOG) pilot study. Int J Pediatr Hematol/Oncol 1996;3:483-90.
14. RTOG/EORTC. Late effects consensus conference: RTOG/ EORTC. Radiother Oncol 1995;35:5-7.
15. Rubin P, Constine LS, Fajardo LF, Phillips TL, Wasserman TH. Overview of late effects normal tissues (LHNT) scoring system. Radiother Oncol 1995;35:9-10.
16. Pavy JJ, Denekamp J, Letschert J, Littbrand B, Mornex F, Bernier J, et al. Late effects toxicity scoring: the SOMA scale. Radiother Oncol 1995;35:11-5.
17. National Cancer Institute. Common Toxicity Criteria, version 2. Bethesda, MD: National Cancer Institute, 1998.
18. Lipshultz SE, Lipsitz SR, Mone SM, Goorin AM, Sallan SE, Sanders SP, et al. Female sex and drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer. N Engl J Med 1995;332:1738-43.
19. Grenier MA, Lipshultz SE. Epidemiology of anthracycline cardiotoxicity in children and adults. Semin Oncol 1998;25(4 Suppl 10):72-85.
20. Giantris A, Abdurrahman L, Hinkle A, Asselin B, Lipshultz SE. Anthracycline-induced cardiotoxicity in children and young adults. Crit Rev Oncol Hematol 1998;27:53-68.
21. Arico M, Maggiore G, Silini E, Bono F, Vigano C, Cerino A, et al. Hepatitis C virus infection in children treated for acute lymphoblastic leukemia. Blood 1994;84:2919-22.
22. Dibenedetto SP, Ragusa R, Sciacca A, Di Cataldo A, Miraglia V, D'Amico S, et al. Incidence and morbidity of infection by hepatitis C virus in children with acute lymphoblastic leukaemia. Eur J Pediatr 1994;153:271-5.
23. Locasciulli A, Testa M, Pontisso P, Benvegnu L, Fraschini D, Corbetta A, et al. Prevalence and natural history of hepatitis C infection in patients cured of childhood leukemia. Blood 1997;90:4628-33.
24. Stevens MCG, Mahler H, Parkes S. The health status of adult survivors of cancer in childhood. Eur J Cancer 1998;34:694-8.
25. Breslow N, Olshan A, Beckwith B, Moksness J, Feigl P, Green D. Ethnic variation in the incidence, diagnosis, prognosis and follow-up of children with Wilms tumor. J Natl Cancer Inst 1994;86:49-51.